Indaptus Other Operating Expenses from 2010 to 2025
| INDP Stock | USD 11.60 0.29 2.56% |
Other Operating Expenses | First Reported 2015-03-31 | Previous Quarter 4.2 M | Current Value 4.6 M | Quarterly Volatility 3.4 M |
Check Indaptus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Indaptus Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 698, Other Operating Expenses of 14.7 M or Research Development of 9.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.9. Indaptus financial statements analysis is a perfect complement when working with Indaptus Therapeutics Valuation or Volatility modules.
Indaptus | Other Operating Expenses | Build AI portfolio with Indaptus Stock |
Latest Indaptus Therapeutics' Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Indaptus Therapeutics over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Indaptus Therapeutics. It is also known as Indaptus Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Indaptus Therapeutics' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Indaptus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Indaptus Other Operating Expenses Regression Statistics
| Arithmetic Mean | 14,538,389 | |
| Geometric Mean | 11,155,846 | |
| Coefficient Of Variation | 80.32 | |
| Mean Deviation | 8,412,408 | |
| Median | 13,846,000 | |
| Standard Deviation | 11,677,375 | |
| Sample Variance | 136.4T | |
| Range | 39.7M | |
| R-Value | 0.31 | |
| Mean Square Error | 132.3T | |
| R-Squared | 0.09 | |
| Significance | 0.25 | |
| Slope | 754,206 | |
| Total Sum of Squares | 2045.4T |
Indaptus Other Operating Expenses History
About Indaptus Therapeutics Financial Statements
Indaptus Therapeutics shareholders use historical fundamental indicators, such as Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Indaptus Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Indaptus Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Indaptus Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 15.4 M | 14.7 M |
Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.